Glaxo Smith Kline (BIOC)

Last update: 22 July 01:29 PM market time.

44.40

0.27

0.61%

Open 44.13

Previous Close 44.13

High 45.40

Low 43.90

Stock Statistics

Volume 202,911

Turnover 9,073,262.00

All data are 15 minutes late during market session

Announcements

14 May 09:29 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

5 May 03:28 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form concerning the BoD & the Shareholders' Structure

4 May 03:06 PM Egyptian Stock Exchange Release from Glaxo Smith Kline (BIOC.CA) Concerning the AGM

9 March 10:29 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports Year Ended 31/12/2024 Consolidated Results

9 March 10:20 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

15 January 04:17 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

14 November 2024 03:01 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports 9 Months Standalone Results

14 November 2024 11:07 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

14 November 2024 11:03 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports 9 Months Consolidated Results

15 October 2024 08:52 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

15 August 2024 09:18 AM Egyptian Stock Exchange Release from Glaxo Smith Kline (BIOC.CA) Concerning the BoD & the Executive Managers

14 August 2024 09:26 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports 6 Months Consolidated Results

14 August 2024 09:22 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

15 July 2024 03:19 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

9 July 2024 02:39 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

9 July 2024 02:37 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

9 July 2024 02:35 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

1 July 2024 03:04 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Declares Cash Dividends

27 June 2024 02:45 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Listing Committee Decision

15 May 2024 09:08 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

29 April 2024 08:57 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Corporate Governance Report

29 April 2024 08:56 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - AGM Decisions

4 April 2024 02:34 PM Egyptian Stock Exchange Release from Glaxo Smith Kline (BIOC.CA) Concerning the AGM